Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Edwards Lifesciences urged a federal appeals court to ignore the alleged “scare tactics” put forward by Medtronic in an effort to forestall a pending ban on U.S. sales of Medtronic’s CoreValve replacement heart valve.
Earlier this month Judge Gregory Sleet of the U.S. District Court for Delaware granted a preliminary injunction to Edwards, limiting U.S. sales of the CoreValve transcatheter aortic heart implant to patients deemed unsuitable for Edwards’ rival Sapien device. Read more
Virginia podiatrist Dr. Ilene Terrell drew a jail sentence yesterday for lying to federal investigators probing Orthofix International and its bone-growth stimulators.
Terrell was sentenced to 5 months in jail, 5 months of home confinement, 2 years of supervised release and a $15,000 fine, according to the office of the Massachusetts U.S. district attorney. Read more
Medtronic said data from a pair of clinical trials evaluating its Endurant stent graft for abdominal aortic aneurysms “affirm the Endurant stent graft’s durable, consistent and proven outcomes.”
The data, from the independent Pandora study and the Medtronic-sponsored Engage trial, showed low rates of “aneurysm-related” mortality, reintervention, stent graft migration and conversion to open surgery, according to a press release. Read more